Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	11394.84	-2087.92	18.16
Graham Fair Price	-78.95	5.75	27.32
PEG	-29.38	-0.50	0.70
Price/Book	337.99	7.42	1.69
Price/Cash Flow	479.11	153.77	-26.55
Prices/Earnings	461.76	40.33	7.18
Price/Sales	750.58	114.77	13.49
Price/FCF	479.11	153.77	-26.55
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.91	0.94	0.99
Operating Margin	-91.08	-0.06	0.63
ROA	-17.08	0.03	0.04
ROE	0.06	0.05	-22.03
ROIC	0.06	< 0.005	-97.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	0.35	-96.69
Dividends QOQ	1.04	-0.86	-17.46
EBIT QOQ	0.29	-1.01	253.61
EPS QOQ	0.10	-0.81	695.49
FCF QOQ	-1.99	1.18	-40.64
Revenue QOQ	0.30	-0.88	191.82
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	63046.25	9148.06	-85.49
Days Sales Outstanding (DSO)	238.42	505.38	111.98
Inventory Turnover	< 0.005	< 0.005	589.18
Debt/Capitalization	0.05	0.10	124.00
Quick Ratio	9.80	0.83	-91.51
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	23.72	5.65	-76.16
Cash	20.27	0.02	-99.89
Capex	-0.01	-0.10	-821.38
Free Cash Flow	-1.51	0.27	-81.97
Revenue	2.98	0.37	-87.73
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.80	0.83	4.16
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.28	-31.25	-852.42
Naive Interpretation	Member

06 - Financial Health · Bad

Rating